United States Zoonotic Disease Treatment Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

Global Zoonotic Disease Treatment market is expected to grow at high CAGR during the forecast period 2024-2031.

Key Development:

United States: Recent Industry Developments

✅ In August 2025, the U.S. government announced a $100 million investment in HERA Invest, a program supporting innovative SMEs in early and late clinical trials. This initiative focuses on medical countermeasures addressing cross-border health threats, including zoonotic diseases.

✅ In July 2025, Public Health Vaccines (PHV) initiated mid-stage human trials for its Nipah virus vaccine candidate, PHV02, in Bangladesh. The vaccine has shown promising results in early trials, demonstrating strong safety and immunogenicity in both one- and two-dose regimens.

✅ In May 2025, the U.S. Department of Health and Human Services (HHS) launched the first national One Health framework. This initiative establishes a unit that brings together representatives from 24 federal agencies to combat zoonotic diseases and strengthen surveillance and response systems.

Japan: Recent Industry Developments

✅ In August 2025, Japan's Ministry of Health, Labour and Welfare invested an additional USD 1 million to support the Global Antibiotic Research and Development Partnership (GARDP). The funding aims to develop new treatments for drug-resistant infections, including those of zoonotic origin.

✅ In September 2024, researchers in Japan's Yamaguchi prefecture discovered that over 60% of bats were infected with at least one strain of potentially zoonotic viruses. This finding underscores the need for enhanced surveillance and preventive measures to mitigate outbreak risks.

✅ In May 2024, the Japanese government approved favipiravir as the first therapeutic agent for Severe Fever with Thrombocytopenia Syndrome (SFTS). This marks a significant advancement in treating SFTS, a tick-borne zoonotic disease with high mortality.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/zoonotic-disease-treatment-market?sb

Zoonotic disease treatment refers to medical strategies and therapies aimed at preventing, managing, or curing diseases that are transmitted from animals to humans. Treatments include antivirals, antibiotics, vaccines, and supportive care, with a focus on early detection, containment, and reducing public health risks.

Recent Mergers and acquisitions:

United States: Recent M&A Activity
✅ In August 2025, Kemin Industries, based in Des Moines, acquired Hennessy Research Associates of Lenexa, Kansas. This acquisition strengthens Kemin's capabilities in animal vaccine development, particularly in the companion animal sector.

✅ In June 2025, Novartis completed its acquisition of Regulus Therapeutics Inc. This move expands Novartis' portfolio in the field of infectious diseases, potentially impacting zoonotic disease treatment strategies.

Key Players:

=> Merck & Co., Inc, GlaxoSmithKline plc, Pfizer, Inc., Sanofi S.A., Novartis AG, Johnson & Johnson, AstraZeneca Plc, Zydus Lifesciences Limited, F Hoffmann-La Roche Inc., Eli Lilly and Company among others.

Growth Forecast Projected:

The Global Zoonotic Disease Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Zoonotic Disease Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=zoonotic-disease-treatment-market

Key Segments:

➥ By Disease Type: Rabies, Hepatitis, Lyme Disease, Plague, Malaria, Others
➥ By Causative Agent: Bacteria, Virus, Nematodes, Rodents, Ticks, Others
➥ By Drug Type: Antifungal Medication, Antibacterial Medication, Antibiotics, Others
➥ By End Users: Hospitals & Clinics, Ambulatory Surgical Centers, Others

Regional Analysis for Zoonotic Disease Treatment Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Zoonotic Disease Treatment producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Zoonotic Disease Treatment revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/zoonotic-disease-treatment-market?sb

FAQ

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.